Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Tropical Storm Danas likely to form Saturday, could approach Taiwan
07/04/2025 12:30 PM - Business
TSMC to withdraw GaN semiconductor business in 2 years
07/04/2025 12:17 PM - Politics
Taiwan's ambassador to Holy See presents Letter of Credence
07/04/2025 10:55 AM - Society
Brief showers forecast for Friday; tropical storms may be forming
07/04/2025 10:34 AM - Business
U.S. dollar down in Taipei trading
07/04/2025 10:20 AM